Effects of oral administration of lactulose in healthy horses

Journal of Equine Veterinary Science

Volumn 18, Issue 6, 1998, Pages 405-408

  Scarratt, W Kent ^a   Warnick, Lorin D ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032382042     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0737-0806(98)80587-X     Document Type: Article

References (23)

1. Hoyumpa AM, Schenker S: Perspectives in hepatic encephalopathy. J Lab Clin Med 1982;100:477.
2. Morris DD, Henry MH: Hepatic encephalopathy. Comp Cont Ed Pract Vet 1991;13:1153.
3. Basile AS, Jones EA, Skolnick P: The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharm Rev 1991;43:27.
4. Zieve L, Nicoloff DM: Pathogenesis is of hepatic coma. Ann Rev Med 1975;26:143.
5. Maddison JE: Hepatoencephalopathy: current concepts of the pathogenesis. J Vet Int Med 1992;6:341.
6. Divers TJ: Liver disease and liver failure in horses. Proc Am Assoc Equine Pract 1983;29:213.
7. Pearson EG: Therapy of liver failure. In: Smith BP (ed), Large Animal Internal Medicine. St. Louis: CV Mosby 1996;913-949.
8. Byars TD: Chronic liver failure In horses. Comp Cont Ed Pract Vet 1983;5:S423.
9. Fraser CL, Arieff AI: Hepatic encephalopathy. N Engl J Med 1985;313:865.
10. Bircher J, Muller J, Zurich MD:Treatment of chronic portal systemic encephalopathy with lactulose. Lancet 1966;1:890.
11. Pirotte J, Guffins JM, Devos J: Comparative study of basal arterial ammonemia and orally induced hyperammonemia in chronic portal systemic encephalopathy treated with neomycin, lactulose and an association of neomycin and lactulose. Digestion 1974;10:435.
12. Elkington SG, Floch MH, Conn HO: Lactulose in the treatment of chronic portal systemic encephalopathy. N Engl J Med 1969;281:408.
13. Kaupe C, Sprague T, Gitnick GL: Hypernatremia after the administration of lactulose. Ann Int Med 1977;86:745.
14. Conn HO, Leevy CM, Vlahcevic ZR: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial. Gastroenterology 1977;72:573.
15. Moran MY: The treatment of chronic hepatic encephalopathy. Hepato-Gastroenterology 1991;38:377.
16. Riordan SM, Williams R: Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473.
17. Hardy RM: Hepatic encephalopathy. In: Kirk RW (ed), Current Veterinary Therapy. Philadelphia: WB Saunders, 1995;pp 639-645.
18. Tyler RM: Hepatoencephalopathy: pathophysiology and treatment. Comp Cont Ed Pract Vet 1990;12:1260.
19. Strombeck DR, Guilford WG: Liver: normal function and pathophysiology. In: Strombeck DR (ed), Small Animal Gastroenterology. Davis, CA: Stonegate Publishing, 1979;p475.
20. Anderson NV: Liver and biliary tract. In: Anderson NV (ed), Veterinary Gastroenterology. Philadelphia, PA: Lea and Febiger, 1992;p255.
21. Haemmerli UP, Bircher J: Influence of lactulose treatment on non-ionic diffusion of ammonia in the dog colon. Gastroenterology 1969;56:1163.
22. SAS Technical Report P-229 SAS/STAT Software: Changes and Enhancements. Cary; SAS Institute Inc, 1992.
23. Hintz HF, Lowe JE, Livesay-Wilkins P et al: Studies on equine enterolithiasis. Proc Am Assoc Equine Pract 1988;34:53.